Editas Medicine, Inc. vs Johnson & Johnson — Stock Comparison

EDIT
Editas Medicine, Inc.
$2.90
▼ 3.33%
vs
JNJ
Johnson & Johnson
$227.19
▼ 1.16%
Q·Score Winner
Johnson & Johnson
JNJ7.1/10vs 4.9/10

Q·Score Breakdown

4.9
Bearish
Overall
7.1
Bullish
1.6
Quality
9.3
7.7
Health
6.5
4.3
Growth
5.1
6.8
Valuation
7.3
5.2
Sentiment
6.5
EDIT

Healthy balance sheet and financial position.

low return on equity (-198%).

JNJ

High-quality business with 26% return on equity and 22% profit margins.

earnings contracting 53% year-over-year.

Analyst Consensus

HOLD
Target $5.72 (+97.3%)
9 analysts
BUY
Target $252.42 (+11.1%)
24 analysts

Fundamentals

EDIT
JNJ
Trailing P/E
26.3×
-3.3×
Forward P/E
17.9×
0.0%
Profit Margin
21.8%
-122.0%
Gross Margin
68.0%
-198.1%
ROE
26.4%
-19.2%
Revenue Growth
9.9%
Earnings Growth
-52.9%
2.04
Beta
0.33
Price / Book
$284M
Market Cap
$546.9B
$1 – $5
52-Week Range
$146 – $252

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →